Directed regulation of the human microbiome: contribution to the solution of the demographic problem in Russia
https://doi.org/10.33647/2713-0428-17-3E-99-105
Abstract
In order to solve the demographic problem that has arisen in Russia, comprehensive multilateral approaches are required, aimed at increasing the birth rate and reducing child and adult mortality. One approach to solve this problem is directed regulation of the human microbiome.
About the Authors
V. M. Abramov
Institute of Immunological Engineering
Russian Federation
Russian Federation
Dr. Sci. (Biol.), Prof.,
142380, Moscow Region, Chekhov District, Lyubuchany, Nauchnaya Str., 1
I. V. Kosarev
Institute of Immunological Engineering
Russian Federation
Russian Federation
Cand. Sci. (Biol.),
142380, Moscow Region, Chekhov District, Lyubuchany, Nauchnaya Str., 1
T. V. Priputnevich
National Medical Research Center for Obstetrics, Gynecology and Perinatology named after Academician V.I. Kulakov of the Ministry of Health Care of Russia
Russian Federation
Russian Federation
Dr. Sci. (Med.), Prof.,
117997, Moscow, Akademika Oparina Str., 4
V. S. Khlebnikov
Institute of Immunological Engineering
Russian Federation
Russian Federation
Dr. Sci. (Biol.), Prof.,
142380, Moscow Region, Chekhov District, Lyubuchany, Nauchnaya Str., 1
R. N. Vasilenko
Institute of Immunological Engineering
Russian Federation
Russian Federation
Cand. Sci. (Biol.),
142380, Moscow Region, Chekhov District, Lyubuchany, Nauchnaya Str., 1
S. Yu. Pchelintsev
Institute of Immunological Engineering
Russian Federation
Russian Federation
Dr. Sci. (Med.), Prof.,
142380, Moscow Region, Chekhov District, Lyubuchany, Nauchnaya Str., 1
V. N. Karkischenko
Scientific Center of Biomedical Technologies of the Federal Medical and Biological Agency of Russia
Russian Federation
Russian Federation
Dr. Sci. (Med.), Prof.,
143442, Moscow Region, Krasnogorsk District, Svetlye Gory Village, 1
A. V. Machulin
Federal Research Center “Pushchino Scientific Center for Biological Research of the Russian Academy of Sciences”
Russian Federation
Russian Federation
Cand. Sci. (Biol.),
142290, Moscow Region, Pushchino, Science Avenue, 3
T. N. Abashina
Federal Research Center “Pushchino Scientific Center for Biological Research of the Russian Academy of Sciences”
Russian Federation
Russian Federation
Cand. Sci. (Biol.),
142290, Moscow Region, Pushchino, Science Avenue, 3
V. A. Samoilenko
Federal Research Center “Pushchino Scientific Center for Biological Research of the Russian Academy of Sciences”
Russian Federation
Russian Federation
Cand. Sci. (Biol.),
142290, Moscow Region, Pushchino, Science Avenue, 3
M. T. Gasanov
Scientific Center of Biomedical Technologies of the Federal Medical and Biological Agency of Russia
Russian Federation
Russian Federation
Cand. Sci. (Med.), Assoc. Prof.,
143442, Moscow Region, Krasnogorsk District, Svetlye Gory Village, 1
V. N. Uversky
University of South Florida
United States
United States
Dr. Sci. (Phys.-Math.), Prof.,
33620, Florida, Tampa, 4202 E. Fowler Avenue
A. V. Karlyshev
Kingston University London
Russian Federation
Russian Federation
Cand. Sci. (Biol.), Prof.,
KT1 1LQ, London, Surrey, Kingston upon Thames, 53-57 High Str., River House
References
1. Ardatskaya M.D. Maslyanaya kislota i inulin v klinicheskoy praktike: teoreticheskie aspekty i vozmozhnosti klinicheskogo primeneniya [Butyric acid and inulin in clinical practice: theoretical aspects and possibilities of clinical use]. Moscow: Forte print Publ., 2014:64. (In Russian).
2. Boytsov S.A., Balanova Yu.A., Shalnova S.A., et al. Arterial’naja gipertonija sredi lic 25–64 let: rasprostranjonnost’, osvedomljonnost’, lechenie i kontrol’. Po materi alam issledovanija ESSE [Arterial hypertension among individuals of 25–64 years old: prevalence, awareness, treatment and control. By the data from ECCD]. Kardiovaskulyarnaya terapiya i profilaktika [Cardiovascular Therapy and Prevention]. 2014;13(4):4–14. (In Russian). DOI: 10.15829/1728-8800-2014-4-4-142.
3. Arumugam M., Raes J., Pelletier E., et al. Enterotypes of the human gut microbiome. Nature. 2011;473(7346):174–180. DOI: 10.1038/nature09944.
4. Cani P., Delzenne N. The role of the gut microbiota in energy metabolism and metabolic disease. Curr. Pharm. Des. 2009;15(13):1546–1558. DOI: 10.2174/138161209788168164.
5. Franceschi C., Garagnani P., Vitale G., Capri M., Salvioli S. Inflammaging and ‘Garb-aging’. Trends Endocrinol. Metab. 2017;28(3):199–212. DOI: 10.1016/j.tem.2016.09.005.
6. Kim J., Jun J.M., Kim M.K., Kwon O., Cho B. Lactobacillus gasseri BNR17 supplementation reduces the visceral fat accumulation and waist circumference in obese adults: A randomized, double-blind, placebo-controlled trial. J. Med. Food. 2018;21(5):454– 461. DOI: 10.1089/jmf.2017.3937.
7. Lee S., Bose S., Seo J., et al. The effects of co-administration of probiotics with herbal medicine on obesity, metabolic endotoxemia and dysbiosis: A randomized double-blind controlled clinical trial. Clin. Nutr. 2014;33(6):973–981. DOI: 10.1016/j.clnu.2013.12.006.
8. Lew S., Hor Y., Jaafar M., et al. Lactobacilli modulated AMPK activity and prevented telomere shortening in ageing rats. Benef. Microbes. 2019;10(8):883–892. DOI: 10.3920/BM2019.0058.
9. Ritter A., Kreis N., Louwen F., Yuan J. Obesity and COVID-19: Molecular linking both pandemics. Int. J. Mol. Sci. 2020;21(16):5793. DOI: 10.3390/ijms21165793.
Review
For citations:
Abramov V.M., Kosarev I.V., Priputnevich T.V., Khlebnikov V.S., Vasilenko R.N., Pchelintsev S.Yu., Karkischenko V.N., Machulin A.V., Abashina T.N., Samoilenko V.A., Gasanov M.T., Uversky V.N., Karlyshev A.V. Directed regulation of the human microbiome: contribution to the solution of the demographic problem in Russia. Journal Biomed. 2021;17(3E):99-105. (In Russ.) https://doi.org/10.33647/2713-0428-17-3E-99-105
Views:
429
Email this article 
